Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial
Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial
复制标题
DOI:
10.1097/ccm.0b013e31816f49ac
复制
发表时间:
2008-05-01
影响因子:
8.8
通讯作者:
Yang, Pan-Chyr
中科院分区:
文献类型:
--
作者:
Chien, Jung-Yien;Lin, Mao-Shin;Yang, Pan-Chyr
Objective. Despite the use of spontaneous breathing trial (SBT), predicting weaning success remains a major clinical challenge. Because cardiovascular dysfunction could be a major underlying mechanism of weaning failure, we evaluated the role of the levels of B-type natriuretic peptide (BNP), a marker for cardiovascular function, in patients who passed a 2-hr SBT.Design, Setting, and Patients: Fifty-two patients recovering from acute respiratory failure were enrolled as the testing group to determine the predictive value of BNP. The predictive value of BNP was validated in a second independent cohort of 49 patients. Then, we combined both groups of patients to conduct the final analysis.Measurements and Results: In the testing group of 52 patients, 41 passed SBT and were extubated. Of these patients, 33 patients (80%) were extubated successfully (extubation success) while eight patients (20%) were reintubated within 48 hrs (extubation failure). There were no differences in the baseline BNIP levels, but the extubation failure group had significantly greater increases in BNP at the end of SBT than the extubation success groups (32.7%, 25(th)-75(th) percentile = 25.7%-50.8% vs. 0.69%, -8.8%-10.72%, p